CoreBone Raises Funds for Bioactive Bone Graft
The investment will be used to extend CoreBone's commercial global presence, primarily in China, with coral-based bone graft....
The investment will be used to extend CoreBone's commercial global presence, primarily in China, with coral-based bone graft....
Paragon 28 is focused on orthopedic solutions, procedural approaches and instrumentation cover a wide range of foot and ankle ailments....
The funding will support technology infrastructure and continued product expansion with specific focus on the U.S. extremity market....
Proceeds will further advance the company's regenerative medicine pipeline of orthobiologic products. ...
Proceeds will support development, commercialization and manufacturing growth in surgical solutions for musculoskeletal oncology and complex orthopedics....
Funds will support launch of new trauma products and further address implant instability across all orthopedic specialties....
The announcement is the largest publicly disclosed funding we can remember in recent years....
The company is pursuing commercialization of personalized knee replacement robot and implants....
The funding will support product development and manufacturing to meet increasing market demand for pediatric orthopedic devices....
The funds will support postmarket clinical studies of the Tapestry Biointegrative impland and launch of the RCR for rotator cuff...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.